ByTrending Posts
Can This AI-Driven Biotech Duo Cut Biologic Development…
Key Highlights • AI-driven protein production from Axio BioPharma integrates with Likarda’s Core-Shell Spherification® (CSS®) delivery platform to…
95 Pathologists, 11 Hospitals, 1 AI Platform: Can…
Key Takeaways• 95 pathologists across 11 hospitals to adopt PathAI’s AISight® digital pathology platform, enabling real-time, AI-enhanced diagnostics•…
How Are the 2025 MedTech Breakthrough Awards Shaping…
Key Highlights: 1. TrustCommerce and Waystar: Leaders in Healthcare Payments InnovationTrustCommerce, a Sphere Company, has been honored with…
How Peerbridge Health’s AI-Powered Cardiac Wearable Clinched the…
Key Highlights AI-Driven Innovation Revolutionizing Cardiac Diagnostics: Peerbridge Health’s Peerbridge Cor® is the first AI-powered wearable bringing hospital-grade…
How Xsolis’ AI-Driven Dragonfly Clinched the 2025 MedTech’s…
Key Highlights Xsolis Sets New Standard in AI-Powered Clinical EfficiencyTennessee-based AI tech firm Xsolis has won top honors…
25 AI-Driven Companies Leading, Top the 2025 Transformation:…
Key Highlights AI-First Innovation Is No Longer Optional—It’s the Industry Standard The 2025 MedTech leaderboard showcases how artificial…
How AccurKardia’s Award-Winning AccurECG™ Platform Redefine ECG Diagnostics…
Key Highlights: A Landmark Recognition for a Game-Changing ECG Technology AccurKardia’s AccurECG™ has been named the “Best New…
Can MIT and Recursion’s New AI Model Boltz-2…
Key Takeaways• Boltz-2 delivers AI-driven binding affinity predictions 1000x faster than traditional free energy methods—dramatically accelerating virtual screening…
Is Optic and Mechanica’s AI Venture Model the…
Key Highlights Strategic Collaboration to Power AI-Led Biotech GrowthOptic, Inc., a pioneer in AI platforms for biopharma, has…
Trending Posts
Latest Stories
Is Pfizer’s $500 Million AI Investment in 2025 Poised to Redefine Drug Discovery and Commercialization?
Global – December 31, 2025 — Pfizer Inc. significantly increased investment in artificial intelligence (AI)…
Is Biopharma’s $8.5 Billion AI Investment in 2025 Across Discovery, R&D, and Commercialization Shaping the 2026 Innovation Landscape?
Global – December 31, 2025 — Biopharmaceutical companies significantly increased investment in artificial intelligence (AI)…
Does BioMark’s 2025 Corporate Update Mark the Shift from Clinical Validation to Commercial-Scale Growth in Lung Cancer Diagnostics?
Executive Summary BioMark’s 2025 corporate update marks a decisive inflection point as the company completes…
Does Allarity Therapeutics’ Year-End Strategic Update Signal Renewed Momentum for Stenoparib in Hard-to-Treat Cancers?
Global – December 2025 — Allarity Therapeutics (NASDAQ: ALLR) has outlined key strategic and operational…
Gallery
